tiprankstipranks
Q-linea AB (DE:3F8)
FRANKFURT:3F8
Germany Market
Holding DE:3F8?
Track your performance easily

Q-linea AB (3F8) Stock Price & Analysis

0 Followers

3F8 Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

100.00%
Insiders
― Other Institutional Investors
100.00% Public Companies and
Individual Investors

3F8 FAQ

What was Q-linea AB’s price range in the past 12 months?
Q-linea AB lowest stock price was €0.05 and its highest was €0.36 in the past 12 months.
    What is Q-linea AB’s market cap?
    Currently, no data Available
    When is Q-linea AB’s upcoming earnings report date?
    Q-linea AB’s upcoming earnings report date is Feb 13, 2025 which is in 78 days.
      How were Q-linea AB’s earnings last quarter?
      Q-linea AB released its earnings results on Nov 05, 2024. The company reported -€0.032 earnings per share for the quarter, beating the consensus estimate of -€0.035 by €0.003.
        Is Q-linea AB overvalued?
        According to Wall Street analysts Q-linea AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Q-linea AB pay dividends?
          Q-linea AB does not currently pay dividends.
          What is Q-linea AB’s EPS estimate?
          Q-linea AB’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Q-linea AB have?
          Q-linea AB has 117,166,374 shares outstanding.
            What happened to Q-linea AB’s price movement after its last earnings report?
            Q-linea AB reported an EPS of -€0.032 in its last earnings report, beating expectations of -€0.035. Following the earnings report the stock price went up 5.882%.
              Which hedge fund is a major shareholder of Q-linea AB?
              Currently, no hedge funds are holding shares in DE:3F8
              ---

              Q-linea AB Stock Smart Score

              10
              Unlock Smart Score
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Fundamentals

              Return on Equity
              -162.66%
              Trailing 12-Months
              Asset Growth
              -50.60%
              Trailing 12-Months

              Company Description

              Q-linea AB

              Q-linea AB is a company that develops solutions for improved infectious disease diagnostics. It focuses on developing instruments and consumables that benefit patients, healthcare providers, and society. It develops and delivers solutions for healthcare providers, enabling them to diagnose and treat infectious diseases in the shortest possible time. The company's product, ASTar, is a fully automated instrument (AST, antibiotic susceptibility testing), which produces a sensitivity profile from a positive blood culture.
              ---
              Popular Stocks
              ---
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis